RCP Inc.

Search Open Menu

In This Issue

  1. PHMSA Stay of Enforcement for API Specification 5L
  2. DOT Final Rule on Implementing Drug Testing Program
  3. PHMSA Revision Request for National Pipeline Mapping System Program
  4. PHMSA ADB-2019-01 Advisory Bulletin Pipeline Damage from River Flooding
  5. PHMSA ADB-2019-02 on Potential for Damage to Pipeline Facilities Caused by Earth Movement and Other Geological Hazards
  6. Gas Pipeline Advisory Committee Meeting Notice
  7. PHMSA Debrief on CAAP Project for Material Strength
  8. AGA White Paper for Natural Gas Systems
  9. One Call Concepts Withdraws from the State of Texas (Lone Star 811)
  10. ASME Pipeline Geo-Environmental Design and Geohazard Management
  11. Fundamentals of Pipeline Operations Workshop
  12. 2019 Summer Industry Conference Schedule
  13. Job Opening – Executive Director of the Pipeline Safety Trust

DOT Final Rule on Implementing Drug Testing Program

On April 23, 2019, the US Department of Transportation (DOT) adopted changes to its drug testing regulations to make the different drug testing programs more consistent. For the pipeline industry, the change was to the definition of a prohibited drug in 49 CFR 199.3. The new definition is now “any of the substances specified in 49 CFR part 40.”  DOT also changed Appendix H in 49 CFR 40 which is the form PHMSA requires large operators (more than 50 covered persons) to report testing results. These changes are effective as of April 23, 2019.

For a copy of DOT’s Final Rule posted in the Federal Register, contact Jessica Foley.